Does Teva's Terrible Tumble Make Its Stock a Buy?
Disappointing financial results, a dividend cut, and reduced guidance have caused Teva Pharmaceutical Industries (NYSE: TEVA) shares to lose half their value in the past month. Can a restructuring help management reduce debt and kick-start shares, or is this company's share price on its way to zero?
In this clip from the Motley Fool's Industry Focus: Healthcare podcast, analyst Kristine Harjes and contributor Todd Campbell explain why Teva Pharmaceutical's share price is tumbling and if investors should be bargain hunting or avoiding this company's stock.
A full transcript follows the video.
Source: Fool.com
Teva Pharmaceutical Industries Ltd ADR Stock
€15.80
1.610%
With 17 Buy predictions and not the single Sell prediction the community is currently very high on Teva Pharmaceutical Industries Ltd ADR.
With a target price of 18 € there is a slightly positive potential of 13.92% for Teva Pharmaceutical Industries Ltd ADR compared to the current price of 15.8 €.
